Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection
Avtorji:ID Hribernik, Nežka, Onkološki inštitut (Avtor)
ID Požek, Igor, Klinika Golnik (Avtor)
ID Kern, Izidor, Klinika Golnik (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (969,72 KB)
MD5: 50AE475AF2354BE07010C70D9821B666
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
Povzetek:Background. The outcomes of patients with both lung cancer and idiopathic pulmonary fibrosis (IPF) are unfavorable. Therapeutic interventions for lung cancer such as surgery can cause acute exacerbation of IPF (aeIPF). This study aimed to assess the frequency of IPF in a group of patients with early-stage non-small-cell lung cancer (NSCLC) and to report clinical characteristics and outcomes of this cohort of patients. Patients and methods. This observational cohort retrospective study analyzed 641 pathological records of patients after surgical resection of early-stage non-small-cell lung cancer (NSCLC) at University Clinic Golnik from May 2010 to April 2017. Pathological records of NSCLC with coexisting IPF were reviewed. CT scans and biopsy specimens for this group of patients were analyzed by a thoracic radiologist and pathologist, independently. We searched radiological and pathological features of usual interstitial pneumonia (UIP) pattern in this group of patients. We report the clinical characteristics and outcome of this cohort of patients. Results. Out of 641 patients with early-stage NSCLC, only 13 (2.0%) had histologically and radiologically proven coexisting UIP/IPF. Squamous cell carcinoma was the most common type of lung cancer (7/13 patients). The majority of tumors were small size (all being pT1 or pT2), stage I–II (11/13 patients), located in the lower lung lobes (11/13 patients). Almost all patients were current or ex-smokers (11/13 patients). There were two pathologically confirmed fatal cases (15.4%) due to aeIPF in the first two months after radical treatment, one after adjuvant radiotherapy and the other after surgery. Out of 13 patients, one patient had a lung cancer relapse. Conclusions. Frequency of UIP/IPF in surgically treated early stage NSCLC is rather low. Our observational study shows that radical treatment of lung cancer can cause aeIPF with dismal outcome in this group of patients. The standard of care in these mostly elderly patients still remains unresolved.
Ključne besede:non-small-cell lung cancer, early-stage cancer, idiopathic pulmonary fibrosis, surgery, radiotherapy
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Kraj izida:Slovenija
Založnik:Sciendo
Leto izida:2019
Št. strani:str. 357-361
Številčenje:Vol. 53, no. 3
PID:20.500.12556/DiRROS-12526 Novo okno
UDK:616.2
ISSN pri članku:1318-2099
DOI:10.2478/raon-2019-0032 Novo okno
COBISS.SI-ID:3298171 Novo okno
Avtorske pravice:© 2019 Hribernik Nezka, Pozek Igor, Kern Izidor
Datum objave v DiRROS:07.10.2020
Število ogledov:2050
Število prenosov:882
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Radiology and oncology
Skrajšan naslov:Radiol. oncol.
Založnik:Slovenian Medical Society - Section of Radiology, Croatian Medical Association - Croatian Society of Radiology
ISSN:1318-2099
COBISS.SI-ID:32649472 Novo okno

Licence

Licenca:CC BY-NC-ND 3.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 3.0 Nedoločena
Povezava:https://creativecommons.org/licenses/by-nc-nd/3.0/deed.sl
Opis:Dovoljuje kopiranje in razširjanje vsebin v kakršnemkoli mediju in obliki. Primerno morate navesti avtorja, povezavo do licence in označiti spremembe, če so kakšne nastale. To lahko storite na kakršenkoli razumen način, vendar ne na način, ki bi namigoval na to, da dajalec licence podpira vas ali vašo uporabo dela. Te vsebine ne smete uporabiti v komercialne namene. Če vsebino predelate (remixate), uredite ali na njej gradite, spremenjene vsebine ne smete razširjati. Ne smete uporabiti pravnih določil ali tehničnih ukrepov, ki bi pravno omejili ali onemogočilo druge, da bi storili karkoli, kar licenca dovoli.
Začetek licenciranja:26.06.2019

Sekundarni jezik

Jezik:Ni določen
Ključne besede:nedrobnocelični rak pljuč, zgodnji rak, idiopatska pljučna fibroza, kirurgija, radioterapija


Nazaj